- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 171
Lucid Diagnostics lines up IPO
Case Western Reserve University-linked Lucid Diagnostics is seeking an initial public offering that would net it up to $57.5m.
Sep 28, 2021Daily Deal Round Up: September 27, 2021
AEI HorizonX took part in a round for satellite technology provider Isotropic Systems exceeding $35m while esports company Misfits Gaming raised $35m in a Scripps-led round.
Sep 27, 2021Toast tops off $1bn initial public offering
The GV-backed restaurant organisation platform developer has issued $130m in additional shares to close its IPO and has a market capitalisation above $28bn.
Sep 27, 2021Cue Health counts up $200m in IPO
The Johnson and Johnson, Dentsu and Koch Industries-backed diagnostics device developer priced its initial public offering in the middle of its range.
Sep 27, 2021Xpansiv commodifies $100m capital raise
Commonwealth Bank of Australia took part in a round which lifted the ESG-focused marketplace's overall funding to $175m.
Sep 27, 2021Centivo covers $51m funding round
The Boston Consulting Group-backed B Capital Group co-led the round, which will be used to expand Centivo's health insurance service.
Sep 27, 2021June Homes emerges with $50m
SoftBank Ventures Asia has led a $27m series B round for the property rental service, which has come out of stealth with $50m in funding.
Sep 27, 2021Crosschq recruits corporates for $30m series A
Recruitment software provider Crosschq has extended its series A round to $30m with backing from investors including SAP and Slack.
Sep 27, 2021Daily Deal Round Up: September 24, 2021
Sleep apnoea treatment developer Cryosa raised $21m in a Hoya-backed series B round while CommerzVentures led a $17m round for financial tool developer Doconomy .
Sep 24, 2021Garuda gets underway with $72m
Co-founded by Harvard faculty, Garuda has launched with $72m in series A financing to advance blood stem cell therapies.
Sep 24, 2021About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


